Nanovision Technology Co., Ltd

Nanovision Technology, founded in 2014 in China, is a global leader in medical imaging and the pioneering developer of Phased Array Computed Tomography (CT) technology. As the first company worldwide to realize full-body medical Phased Array CT, Nanovision is redefining diagnostic imaging with breakthrough innovations that deliver ultra-high spatial resolution and enable novel clinical applications.

The company maintains comprehensive vertical integration across the entire innovation chain—from fundamental research and algorithm design to component manufacturing and system production—establishing a fully proprietary Phased Array CT technology ecosystem. Its extensive intellectual property portfolio spans all core domains, including system architecture, image reconstruction algorithms, mechanical design, X-ray source arrays, detector modules, application software, and custom integrated circuits. To date, Nanovision has filed over 300 intellectual property applications globally, with nearly 230 IPs granted.

Driven by independent innovation and interdisciplinary expertise, Nanovision combines rigorous scientific research with advanced engineering capabilities to address complex challenges in medical imaging and diagnostics. Through sustained technological breakthroughs and close collaboration with the clinical and academic communities, Nanovision is accelerating the advancement of imaging science, fostering industrial innovation, and contributing to the improvement of global healthcare and human well-being.